Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
Y-mAbs Therapeutics (YMAB) Fails to deliver data
Key failure to deliver metrics for Y-mAbs Therapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.08 M
- Last 3 months FTD volume: $0.66 M
- Last year FTD volume: $1.54 M
Failures to deliver for Y-mAbs Therapeutics (YMAB) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Y-mAbs Therapeutics (YMAB) - since 2018
Volume in USD (price x number of shares), data since 2018Y-mAbs Therapeutics (YMAB) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.66 M | -41.28% |
| 2023 | $1.13 M | -86.55% |
| 2022 | $8.4 M | 0.66% |
| 2021 | $8.34 M | 102.28% |
| 2020 | $4.12 M | -28.11% |
| 2019 | $5.74 M | 154.2% |
| 2018 | $2.25 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.19 M | $6.79 M | 🇺🇸 USA |